Patent US4084001A successfully refreshed from Google Patents.
US4084001A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmacologically active compounds
Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1976-11-23
•
Granted: 1978-04-11
•
Expires: 1996-11-23
Abstract
Abstract The compounds are substituted S-(aminoalkyl)isothioureas which are histamine H2-antagonists. Two specific compounds of the present invention are S-[6-(N'-methylthioureido)hexyl]isothiourea and S-[5-(N'-cyano-N''-methylguanidino)pentyl]isothiourea.
Inventors
- 👤 Graham John Durant
- 👤 Charon Robin Ganellin
- 👤 Robert John Ife
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 01:44
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/96; A; A61; A61P; A61P43/00; C07C; C07C335/00; C07C335/30; C07C335/32
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
32 words
A compound of the formula ##STR8## wherein n is an integer from 3 to 6; R is lower alkyl or ##STR9## X is sulphur; or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim
32 words
A compound of the formula ##STR8## wherein n is an integer from 3 to 6; R is lower alkyl or ##STR9## X is sulphur; or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
11 words
A compound of claim 1 wherein n is 5 or 6.
Claim 4
Dependent Claim
12 words
A compound of claim 1, said compound being a salt of S-[6-(N'-methylthioureido)hexyl]isothiourea.
Claim 5
Dependent Claim
12 words
A compound of claim 1, said compound being a salt of S-[5-(N'-methylthioureido)pentyl]isothiourea.
Claim 6
Dependent Claim
17 words
A compound of claim 1 which is in the form of a pharmaceutically acceptable acid addition salt.
Claim 7
Dependent Claim
42 words
A pharmaceutical composition to block histamine H 2 -receptors comprising in an effective amount to block said receptors a compound of claim 1 in the form of a pharmaceutically acceptable acid addition salt in combination with a pharmaceutically acceptable diluent or carrier.
Claim 8
Dependent Claim
13 words
A pharmaceutical composition of claim 6 in unit dosage form for oral administration.
Claim 9
Dependent Claim
30 words
A method of blocking histamine H 2 -receptors which comprises administering to an animal in need thereof in an effective amount to block said receptors a compound of claim 1.
Claim 10
Dependent Claim
26 words
A method of treating inflammation which comprises administering to an animal in need thereof in an effective amount to treat inflammation a compound of claim 1.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-04-10 | 1981-10-10 | 1982-04-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-04-10 | 1985-10-10 | 1986-04-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-04-10 | 1989-10-10 | 1990-04-11 | $7700.00 | Window Closed / Lapsed |